Optimus Healthcare Services IncOTC Pink - Current Information:OHCS
- LAST PRICE0.0360
- TODAY'S CHANGE (%)-0.0510 (-58.6207%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0360 / 0.0870
- Day Range
- 52 Week Range
- Volume1,350
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OHCS |
|---|---|---|
| 10:30 ET | 1350 | 0.036 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Optimus Healthcare Services Inc | 4.0M | -0.2x | --- |
BioElectronics Corp | 2.5M | -5.0x | --- |
Tivic Health Systems Inc | 2.5M | 0.0x | --- |
Montvale Technologies Inc | 10.0 | 0.0x | --- |
BG Medicine Inc | 10.0 | 0.0x | --- |
Electromedical Technologies Inc | 339.7K | -0.1x | --- |
Company Information
Optimus Healthcare Services, Inc. is a dedicated to advancing access to clinical trial research through its portfolio company Clinical Research Alliance, Inc. (CRA). CRA provides services to a team of dedicated oncologists across the Tri-State area that are united by a shared commitment to conduct clinical research. CRA provides independent, community-based oncology practices and hospitals in diverse communities with the necessary infrastructure and support to enroll their patients in clinical trials without the patients having to leave their physicians' offices, hospitals or their local communities. CRA's focus is on oncology practices, as well as hospitals in diverse communities. CRA contracts with pharmaceutical companies and Contract Research Organizations (CRO) to conduct clinical trials (Phases I-IV) for investigational new drugs, biologics and medical devices. CRA's customers consist primarily of large and mid-sized pharmaceutical and biotech companies.
Contact Information
- Headquarters
- 1400 Old Westbury Road Suite 306, Suite 305WESTBURY, NY, United States 11590
- Phone
- 516-806-4201
- Fax
- ---
Executives
- General Counsel
- Cliff Saffron
- Chief Financial Officer, Senior Vice President
- Thomas Mcneill
- Independent Director
- Eli Avila
- Independent Director
- Teresa Carlson
- Independent Director
- Peter Michalos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0M |
|---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 45.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-0.21 |
Book Value | $-0.18 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -413.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
